Benzinga’s Volume Movers (MNTA, ONXX, IDSA, GENZ)

Momenta Pharmaceuticals Inc

shares gained 9.72% to $23.81 at 1:05 pm. The volume of MNTA shares traded was 1,266% higher than normal. Momenta has received approval from the Food and Drug Administration (FDA) to market a generic version of Sanofi's blood-thinner drug, Lovenox. ONYX Pharmaceuticals Inc

shares moved up 18.70% to $25.52. The volume of ONXX shares traded was 1136% higher than normal. ONXX has announced positive results for its new cancer drug, carfilzomib. Industrial Services of America Inc

shares rose 16.82% to $17.22. The volume of IDSA shares traded was 641% higher than normal. IDSA expects to post its Q2 earnings around $0.33-$0.38 per share. Genzyme Corporation

shares rose 7.58% to $67.26. The volume of GENZ shares traded was 352% higher than normal. Sanofi-Aventis

has approached GENZ for a takeover in an informal way. Read more